EUVIMEDEUVIMED entdecken
Open Access

Impact of Atrial and Dual‐Chamber Leadless Pacing on Subcutaneous Implantable Cardioverter‐Defibrillator Screening Eligibility

Maciej Dyrbuś iD, Adam Sokal, Jakub Baran iD, Anna Kurek, Ewa Świerżyńska-Wodarska, Michał Lewandowski, Paweł Szymkiewicz, Marcin Michalak, Artur Oręziak, Joanna Machowicz, Łukasz Januszkiewicz iD, Andrzej Ząbek und 6 weitere

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Maciej Dyrbuś und 17 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Silesian Center for Heart Diseases in Zabrze, Medical University of Silesia, Kato…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiac Pacing, Artificial, Electrocardiography, Electric Countershock. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Leadless pacemakers (LPs) are increasingly used in patients at high risk of transvenous lead complications. If indications for implantable cardioverter‐defibrillator (ICD) therapy arise later, a subcutaneous ICD (S‐ICD) may represent an attractive option. However, S‐ICD implantation requires pre‐implant electrocardiographic screening, and pacing may impact implantation eligibility. Thus, the purpose of the present analysis was to evaluate S‐ICD screening eligibility in patients with right atrial (RA) and dual‐chamber (DR) LP during intrinsic rhythm, atrial pacing, and dual‐chamber pacing. Methods and Results Patients implanted with active‐fixation RA and dual‐chamber LP systems underwent S‐ICD screening using the automated screening tool. Electrocardiographic parameters were assessed during intrinsic rhythm, atrial pacing (AAI), and dual‐chamber pacing (DDD). Screening eligibility was assessed separately for each rhythm. Combined eligibility was defined as the presence of at least one acceptable vector in intrinsic and paced rhythms. Forty‐one patients were included (median age 67 years; 61% female). During intrinsic rhythm, at least one acceptable vector was present in 91.4% of patients. Screening eligibility remained high during atrial pacing (77.1%) but decreased substantially during dual‐chamber pacing (33.3%). Primary and secondary sensing vectors demonstrated the highest screening success across rhythm conditions, with positive rates of 60.0% and 62.3% for AAI, and 18.5% and 11.1% for DDD pacing.

Conclusion

In patients with RA and DR LPs, S‐ICD screening eligibility is preserved in most cases during intrinsic rhythm and atrial pacing, but markedly reduced during DDD pacing. Pacing mode should be considered when evaluating the feasibility of combining LP systems with an S‐ICD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableCardiac Pacing, ArtificialElectrocardiographyElectric CountershockPacemaker, ArtificialArrhythmias, CardiacHumansFemaleMaleAgedPredictive Value of TestsMiddle AgedHeart RateTreatment OutcomeEquipment DesignAction PotentialsPatient Selection

Stichwörter der Autor:innen

atrial pacingdual‐chamber pacingelectrocardiographyleadless pacemakerscreeningsubcutaneous implantable cardioverter‐defibrillator

Autor:innen und Institutionen

  • 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Silesian Center for Heart Diseases in Zabrze, Medical University of Silesia, Katowice, Poland.
  • 1st Department of Cardiology and Angiology, Silesian Centre for Heart Diseases in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Division of Clinical Electrophysiology, Department of Internal Medicine and Cardiology, Medical University of Warsaw, Poland.
  • 1st Arrhythmia Dept. National Institute of Cardiology, Warsaw, Poland.
  • 2nd Arrhythmia Dept. National Institute of Cardiology, Warsaw, Poland.
  • 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

ORCID-Profile: Maciej Dyrbuś, Jakub Baran, Łukasz Januszkiewicz

Zitieren

APA

Dyrbuś, M., Sokal, A., Baran, J., Kurek, A., Świerżyńska-Wodarska, E., Lewandowski, M., Szymkiewicz, P., Michalak, M., Oręziak, A., Machowicz, J., Januszkiewicz, Ł., Ząbek, A., Boczar, K., Sterliński, M., Grabowski, M., Kalarus, Z., Gąsior, M., & Tajstra, M. (2026). Impact of Atrial and Dual‐Chamber Leadless Pacing on Subcutaneous Implantable Cardioverter‐Defibrillator Screening Eligibility. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70420

Vancouver

Dyrbuś M, Sokal A, Baran J, Kurek A, Świerżyńska-Wodarska E, Lewandowski M, et al. Impact of Atrial and Dual‐Chamber Leadless Pacing on Subcutaneous Implantable Cardioverter‐Defibrillator Screening Eligibility. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70420

BibTeX
@article{Dyrbu2026,
  author = {Dyrbuś, Maciej and Sokal, Adam and Baran, Jakub and Kurek, Anna and Świerżyńska-Wodarska, Ewa and Lewandowski, Michał and Szymkiewicz, Paweł and Michalak, Marcin and Oręziak, Artur and Machowicz, Joanna and Januszkiewicz, Łukasz and Ząbek, Andrzej and Boczar, Krzysztof and Sterliński, Maciej and Grabowski, Marcin and Kalarus, Zbigniew and Gąsior, Mariusz and Tajstra, Mateusz},
  title = {Impact of Atrial and Dual‐Chamber Leadless Pacing on Subcutaneous Implantable Cardioverter‐Defibrillator Screening Eligibility},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70420}
}
Kostenlos starten →